BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21454807)

  • 1. Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4.
    Ding M; Xie Y; Wagner RJ; Jin Y; Carrao AC; Liu LS; Guzman AK; Powell RJ; Hwa J; Rzucidlo EM; Martin KA
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1403-10. PubMed ID: 21454807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
    Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
    J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic Response.
    Jin Y; Xie Y; Ostriker AC; Zhang X; Liu R; Lee MY; Leslie KL; Tang W; Du J; Lee SH; Wang Y; Sessa WC; Hwa J; Yu J; Martin KA
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2311-2321. PubMed ID: 29025710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation.
    Martin KA; Rzucidlo EM; Merenick BL; Fingar DC; Brown DJ; Wagner RJ; Powell RJ
    Am J Physiol Cell Physiol; 2004 Mar; 286(3):C507-17. PubMed ID: 14592809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
    Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR.
    Wagner RJ; Martin KA; Powell RJ; Rzucidlo EM
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C119-27. PubMed ID: 20375271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition.
    Xie Y; Jin Y; Merenick BL; Ding M; Fetalvero KM; Wagner RJ; Mai A; Gleim S; Tucker DF; Birnbaum MJ; Ballif BA; Luciano AK; Sessa WC; Rzucidlo EM; Powell RJ; Hou L; Zhao H; Hwa J; Yu J; Martin KA
    Sci Signal; 2015 May; 8(376):ra44. PubMed ID: 25969542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1.
    Moss SC; Lightell DJ; Marx SO; Marks AR; Woods TC
    J Biol Chem; 2010 Apr; 285(16):11991-7. PubMed ID: 20097763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol induces vascular smooth muscle cell differentiation through stimulation of SirT1 and AMPK.
    Thompson AM; Martin KA; Rzucidlo EM
    PLoS One; 2014; 9(1):e85495. PubMed ID: 24416418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation.
    Wang Y; Bai Y; Qin L; Zhang P; Yi T; Teesdale SA; Zhao L; Pober JS; Tellides G
    Circ Res; 2007 Sep; 101(6):560-9. PubMed ID: 17656678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.
    Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC
    Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells.
    Cao H; Dronadula N; Rao GN
    Am J Physiol Cell Physiol; 2006 Jan; 290(1):C172-82. PubMed ID: 16148030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.
    Zhao Y; Biswas SK; McNulty PH; Kozak M; Jun JY; Segar L
    Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1375-85. PubMed ID: 21325637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
    Liu Y; Fanburg BL
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo.
    Dormond O; Contreras AG; Meijer E; Datta D; Flynn E; Pal S; Briscoe DM
    J Immunol; 2008 Dec; 181(11):8088-95. PubMed ID: 19018001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway.
    Zhan JK; Wang YJ; Wang Y; Tang ZY; Tan P; Huang W; Liu YS
    Exp Cell Res; 2014 May; 323(2):352-8. PubMed ID: 24607448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
    Veilleux A; Houde VP; Bellmann K; Marette A
    Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype.
    Ding M; CarrĂ£o AC; Wagner RJ; Xie Y; Jin Y; Rzucidlo EM; Yu J; Li W; Tellides G; Hwa J; Aprahamian TR; Martin KA
    J Mol Cell Cardiol; 2012 Feb; 52(2):474-84. PubMed ID: 21952104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1.
    Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS
    Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.